Sino-Agri Leading Biosciences ,Ltd EBIT

As of the most recent data (June 2026), 603970.SS shows a EBIT of $260M. That compares with $310M in the prior-year period — down 16.8% year over year. That is below the sector sector average of $2.5T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 603970.SS's EBIT is now $260M (was $310M) — a 16.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sino-Agri Leading Biosciences ,Ltd is outperforming or lagging.

The its sector sector average EBIT is about $2.5T. Sino-Agri Leading Biosciences ,Ltd is at $260M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how 603970.SS stacks up against individual peers as well.

Tracking 603970.SS's ebit over time shows whether Sino-Agri Leading Biosciences ,Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $260M That compares with $310M in the prior-year period — down 16.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Sino-Agri Leading Biosciences ,Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $260M) with ownership activity and broader fundamentals.